Dicella sp. z o.o.

Research and experimental development in natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-11-28
Share capital
121,600.00 PLN
Average employment (people)
6 (2025)
Activity description

Dicella develops an integrated clinical trial platform for sponsors, CROs, and research teams, bringing together eCRF, eTMF, CTMS, IWRS, patient diaries, and study operations. It also offers AI-assisted configuration and blockchain-based data integrity features, supporting teams throughout the clinical trial process.

Registered address
ul. Podole 60, 30-394 Kraków, Poland
Email
Phone
Social media

Financials

Revenue history (in k)

From the notes

Profit allocationRetained in reserve capital
Loans and borrowings$376,526
Capital expenditure$206,911
Foreign sales32.68% of revenue ($73,965)
Revenue structureSprzedaż usług
R&D costs$131,431

Filing timeliness

4 of 6 financial statements were filed late (the longest delay 255 days for 2021).

  • 202522/07/2026
  • 202418/08/2025
  • 202320/06/2024
  • 202231/12/2023
  • 202127/03/2023
  • 202030/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 36%
Top 33%
City · Kraków7,050 / 16,158
Top 44%
Voivodeship · Małopolskie13,222 / 27,734
Top 48%
Country · Poland143,540 / 297,266
Top 48%

Results vs industry

Revenue
This companyUSD 322.19kMedianUSD 153.26kAverageUSD 4.77m
Net profit
This companyUSD 4.33kMedianUSD -293.45AverageUSD 306.55k
Operating costs
This companyUSD 285.49kMedianUSD 188.47kAverageUSD 4.59m
Assets
This companyUSD 1.55mMedianUSD 281.58kAverageUSD 8.35m

Offer

  • Clinical trial software
  • Electronic trial master file system
  • Clinical data capture system
  • Clinical trial management system
  • Clinical trial randomization system
  • Patient diary
  • Diagnostic imaging analytics

Websites

  • dicella.comUnified clinical trial platform for reliable eTMF, eCRF, CTMS and study operations | diCELLa
    Google AnalyticsGoogle Tag ManagerNginx

Public procurement

4 tenders recorded as contractor: 3 national ($135,034) and 1 EU ($237,894).

SubjectAmount
Purchase, delivery and implementation of a clinical trial management system (CTMS) and purchase of additional licences for the amms system, including implementation.
$118.9K
Purchase, delivery and implementation of a clinical trial management system (CTMS) and purchase of additional licences for the amms system, including implementation.
$118.9K
Delivery, implementation and warranty servicing of an electronic patient diary creator (EDP creator) for remote data collection in a clinical trial.
$36,628

Authorized Representatives

Aleksandra Kubica-Misztal age 40 – Management Board Member
Krzysztof Paweł Misztal age 41 – President of the Management Board

Manner of representation

In the case of a multi-member management board, the joint action of two members of the management board, or one member of the management board jointly with a commercial proxy, is required to submit declarations of will concerning the rights and obligations.

Ownership

OwnerSharesShare valueStake
950$12,830.9039.0625%
950$12,830.9039.0625%
532$7,185.3121.875%

Aleksandra Kubica Misztal and Krzysztof Paweł Misztal hold a combined 78.1% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2018-01-05.

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Mar 11, 2019Call to creditors

Public aid

32 public aid cases recorded, with a total value of $1,186,162.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$27,727
De minimis aid (in accordance with Commission Regulation 2023/2831)
$303
De minimis aid (in accordance with Commission Regulation 2023/2831)
$0

European Funds

5 projects co-financed from European Funds recorded, with total EU co-financing of $931,172.

ProjectEU co-financing
eCRF+ML diCELLa clinical trials - electronic patient record supported by machine learning algorithms
$329.9K
qCELLa – conducting research and development work on the analysis of medical images using quantum computers.
$482.3K
diCELLa R&D: Construction of a research and development centre enabling the development of innovative products based on artificial intelligence
$47,564

Competitors

Name
Infomed Software sp. z o.o.
Egabinet sp. z o.o.
Lifelogic sp. z o.o.
Medchart sp. z o.o.
LAB - Bit Software S.A.
Pergamonmed sp. z o.o.
Medsi sp. z o.o.
Notbug sp. z o.o.
Diagu sp. z o.o.
Eprzychodnia sp. z o.o.

Change history

DateEvent
2025-06-05Share capital increase
2025-06-05Switch to PKD 2025
2021-06-21Address change
2019-09-20Address change
2019-07-04Share capital reduction

FAQ

Last updated: 2026-07-22